Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy. Issue 2 (February 2015)

• Record Type: Journal Article
• Authors: Chen, Tzu-Ting; Chiu, Chang-Fang; Yang, Tse-Yen; Lin, Ching-Chan; Sargeant, Aaron M.; Yeh, Su-Peng; Liao, Yu-Min; Bai, Li-Yuan
• Is Part Of: Leukemia research. Volume 39:Issue 2(2015:Feb.)
• Page Start: 151
• Page End: 156
• Publication Date: 2015-02
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2014.11.015
• Languages: English
• ISSNs: 0145-2126

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Examine the impact of HCV infection on DLBCL patients receiving immunochemotherapy.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">29 HCV-positive patients are compared with 139 HCV-negative patients.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">HCV infection results in more hepatic toxicity in DLBCL patients.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">HCV exaggerates hepatic toxicity and delays scheduled treatment.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">HCV infection does not affect 5-year PFS or 5-year OS.</p> </list-item> </list> </p> </sec> </abstract>